| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/06/2004 | US6759530 IBD-associated microbial nucleic acid molecules |
| 07/06/2004 | US6759518 Single-chain multiple antigen-binding molecule, its preparation and use |
| 07/06/2004 | US6759517 Allergenic proteins of natural rubber latex, their production and use in assays |
| 07/06/2004 | US6759516 Methods of identifying antigen gene sequences |
| 07/06/2004 | US6759432 Prevent denaturing of collagen |
| 07/06/2004 | US6759389 Purified recombinant protein consisting of amino acid sequence 3; axonal regeneration; accelerating wound healing while minimizing scar tissue and keloid formation keloid formation. |
| 07/06/2004 | US6759215 Method of preparing human stem cell factor polypeptide |
| 07/06/2004 | US6759213 Haemophilus adhesion proteins |
| 07/06/2004 | US6759211 For cancer use in therapy |
| 07/06/2004 | US6759210 Compositions and methods for the treatment and diagnosis of cardiovascular disease using fehd545 as a target |
| 07/06/2004 | US6759194 Nucleotide sequences encoding peroxisome-associated polypeptides, and their uses in the diagnosis and/or treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 07/06/2004 | US6759189 Early detection of lysosomal storage disorders |
| 07/06/2004 | US6759048 Neutralization-sensitive epitopes of Cryptosporidium parvum |
| 07/06/2004 | US6759045 Administering antibodies; anticancer agents |
| 07/06/2004 | US6759043 Monoclonal antibodies having property of causing apoptosis |
| 07/06/2004 | US6759041 Administering to a patient an effective amount of a fas antagonist |
| 07/06/2004 | CA2105606C Method for the determination of lupus anticoagulant antibodies that cause thrombosis |
| 07/01/2004 | WO2004055513A2 Use of cd137 antagonists for the treatment of tumors |
| 07/01/2004 | WO2004055494A2 Compositions and methods for detecting animal by product in feed |
| 07/01/2004 | WO2004055186A1 Guanosine triphosphate-binding protein-coupled receptor |
| 07/01/2004 | WO2004055164A2 System and method for stabilizing antibodies with histidine |
| 07/01/2004 | WO2004055056A1 Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2 |
| 07/01/2004 | WO2004055051A1 Transcription control factor zhx3 |
| 07/01/2004 | WO2004055043A1 Epitopic peptides of the thyroperoxidase enzyme, compositions containing same and uses thereof |
| 07/01/2004 | WO2004032870A3 Methods for treating post-surgical pain by admisnistering a nerve growth factor antagonist and compositions containing the same |
| 07/01/2004 | WO2004024098A3 Method for the treatment of nephritis using anti-pdgf-dd antibodies |
| 07/01/2004 | WO2004018512A3 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 07/01/2004 | WO2004013151A3 Campylobacter glycans and glycopeptides |
| 07/01/2004 | WO2004009789A3 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 07/01/2004 | WO2004005351A3 Neoplasm specific antibodies and uses thereof |
| 07/01/2004 | WO2004003141A3 A protein that interacts with lipids and methods for treating hyperlipidemia |
| 07/01/2004 | WO2004001007A3 Buffered formulations for concentrating antibodies and methods of use thereof |
| 07/01/2004 | WO2003099996A3 Detection of secreted polypeptides |
| 07/01/2004 | WO2003097666A3 Use of gastrin releasing peptide (grp) and its receptor in cancer screening |
| 07/01/2004 | WO2003091386A3 A new family of picornaviruses |
| 07/01/2004 | WO2003083072A3 In vivo method for determining the biologic efficacy of monoclonal antibodies in animal models of disease states |
| 07/01/2004 | WO2003080569A3 Egfr ligands and methods of use |
| 07/01/2004 | WO2003078600A3 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 07/01/2004 | WO2003068920A3 Humanized gm-csf antibodies |
| 07/01/2004 | WO2003061575A3 Anti-idiotype antibody of disintegrin and uses thereof |
| 07/01/2004 | WO2003003986A3 Parathyroid hormone antibodies and related methods |
| 07/01/2004 | WO2002015846A3 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 07/01/2004 | US20040127689 activated haptens useful for generating immunogens to HIV protease inhibitors |
| 07/01/2004 | US20040127688 Altered antibodies |
| 07/01/2004 | US20040127686 Signal transduction regulator binding protein for identifying modulators for prevention and treatment of cardiomyopic hypertrophy, heart failure and diabetes; drug screening |
| 07/01/2004 | US20040127682 Anti-lymphocyte globulin imunotoxin fusion protein for use in prevention and treatment of graft-versus-host disease, leukemias, lymphomas and autoimmune disorders |
| 07/01/2004 | US20040127408 based on the complementarity-determining region (CDR) of a human monoclonal anti-DNA antibody |
| 07/01/2004 | US20040127401 CA125 gene and its use for diagnostic and therapeutic interventions |
| 07/01/2004 | US20040127400 for inducing antibody production against Streptococcal antigens |
| 07/01/2004 | US20040126898 Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (ANCA) |
| 07/01/2004 | US20040126866 Comprises nucleotide sequences coding cyclic nucleotide phosphodiesterases for treatment of cardiovascular, depressive and vascular disorders; cardiotonic agents; antidepressants; antihypertensives; antithrombotics |
| 07/01/2004 | US20040126862 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 07/01/2004 | US20040126851 Comprises nucleotide sequences coding immunoglobulin which binds chemokine receptor 2 for use in the treatment and prevention of restenosis |
| 07/01/2004 | US20040126839 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/01/2004 | US20040126828 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 07/01/2004 | US20040126816 Using blood coagulation factor to identify antibodies which modulate, prevent and treat tumors, inflammation, septic shock, hypotension and adult respiratory distress syndrome |
| 07/01/2004 | US20040126807 Isolated nucleic acids; polypeptides showing higher expression on cancer cells |
| 07/01/2004 | US20040126801 Novel polynucleotides and encoded polypeptides |
| 07/01/2004 | US20040126789 Compositions and methods for synthesizing nucleic acids |
| 07/01/2004 | US20040126781 Methods of preventing immune-mediated abortion by inhibiting a CD28-mediated costimulatory signal |
| 07/01/2004 | US20040126769 easily altered binding loops and stable beta barrel conformation; manipulative by standard cloning techniques; produced in cultured host cells; long shelf life; genetic engineering |
| 07/01/2004 | US20040126759 Molecules for disease detection and treatment |
| 07/01/2004 | US20040126758 homologous to the known fibrinogen derived haptotactic peptides; shown to elicit activity from fibroblasts, endothelial and smooth muscle cells; for wound healing and enhancing osteogenesis/angiogenesis in vivo with/without medical implant |
| 07/01/2004 | US20040126395 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 07/01/2004 | US20040126391 Meningococcal antigens |
| 07/01/2004 | US20040126390 Recombinant plasmid and a method of controlling the effects of Yersinia pestis |
| 07/01/2004 | US20040126384 Combination of IgY against dental caries |
| 07/01/2004 | US20040126383 Administering polyclonal antibody globulin; neutralization antigens; diarrhea therapy |
| 07/01/2004 | US20040126378 Antibodies to treat cancer |
| 07/01/2004 | US20040126376 Binding to monoclonal antibodies; antitumor agents |
| 07/01/2004 | US20040126374 Administering immunoglobulins, insulin protein, epitopes and lymphocyte receptor; prevention, suppression, delay diabetes |
| 07/01/2004 | US20040126373 Administering tumor necrosis factor antibody; restenosis |
| 07/01/2004 | US20040126372 Administering antibodies; respiratory system disorders; cardiovascular disorders; metabolism disorders; anemia; analgesics; liver disorders; skin disorders |
| 07/01/2004 | US20040126363 Cd19-specific redirected immune cells |
| 06/30/2004 | EP1433849A1 NOVEL POLYPEPTIDE, DNA THEREOF AND USE OF THE SAME |
| 06/30/2004 | EP1433846A2 Phagemid-based method of producing filamentous bacteriophage particles displaying antibody molecules and the corresponding bacteriophage particles. |
| 06/30/2004 | EP1433793A1 Method of constructing camel antibody library |
| 06/30/2004 | EP1433792A2 Human receptor proteins, related reagents and methods |
| 06/30/2004 | EP1432991A1 Identification and isolation of somatic stem cells and uses thereof |
| 06/30/2004 | EP1432810A2 Production of recombinant proteins in vivo and use for generating antibodies |
| 06/30/2004 | EP1432801A2 Receptors and membrane-associated proteins |
| 06/30/2004 | EP1432792A2 Histone deacetylase 9 |
| 06/30/2004 | EP1432738A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 06/30/2004 | EP1432737A2 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor |
| 06/30/2004 | EP1432736A2 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) |
| 06/30/2004 | EP1432735A2 Antagonistic anti-htnfsf13b human antibodies |
| 06/30/2004 | EP1432451A2 Production of fusion proteins and use for identifying binding molecules |
| 06/30/2004 | EP1432447A2 Combined compositions and methods for tumor vasculature coagulation and treatment |
| 06/30/2004 | EP1432446A2 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders |
| 06/30/2004 | EP1432445A2 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex |
| 06/30/2004 | EP1432444A2 Anti-a-beta antibodies |
| 06/30/2004 | EP1432443A2 Angiotensin peptide-carrier conjugates and uses thereof |
| 06/30/2004 | EP1432438A2 Use of rank antagonists to treat cancer |
| 06/30/2004 | EP1432431A2 Methods and compositions for modulating interleukin-21 receptor activity |
| 06/30/2004 | EP1432418A1 Treatment of hepatitis b virus infection with human monoclonal antibodies |
| 06/30/2004 | EP1112366B1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
| 06/30/2004 | EP1054688B1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses |
| 06/30/2004 | EP1009421B1 Compositions for enhanced wound healing |
| 06/30/2004 | EP0862628B1 Receptor and nucleic acid molecule encoding said receptor |
| 06/30/2004 | EP0851876B1 Antisecretory factor peptides regulating pathological permeability changes |